Hyperbaric oxygen therapy ameliorates TNBS-induced acute distal colitis in rats

Abstract

BackgroundThis study investigated the therapeutic effects of hyperbaric oxygen in experimental acute distal colitis focusing on its effect on the production of pro-inflammatory cytokines, nitric oxide and hypoxia-inducible factor 1alpha.MethodsColitis was induced with a rectal infusion of 150 mg/kg of TNBS under anesthesia with Ketamine (50 mg/kg) and Xylazine (10 mg/kg). Control animals received only rectal saline. After colitis induction, animals were subjected to two sessions of hyperbaric oxygen and were then euthanized. The distal intestine was resected for macroscopic analysis, determination of myeloperoxidase activity, western-blotting analyses of inducible nitric oxide synthase and cyclooxygenase-2 expression and immunohistochemical analysis of hypoxia-inducible factor 1alpha and cyclooxygenase-2. Cytokines levels in the distal intestine were measured using an enzyme-linked immunosorbent assay.ResultsHyperbaric oxygen therapy attenuated the severity of acute distal colitis, with reduced macroscopic damage score. This effect was associated with prevention in the increase of pro-inflammatory cytokine production; myeloperoxidase activity, in the expression of inducible nitric oxide synthase and cyclooxygenase-2. Finally, hyperbaric oxygen inhibited the acute distal colitis-induced up-regulation of hypoxia-inducible factor 1alpha.ConclusionsThe results indicate that hyperbaric oxygen attenuates the severity of acute distal colitis through the down-regulation of pro-inflammatory events.

Neuroprotective effect of hyperbaric oxygen therapy in a juvenile rat model of repetitive mild traumatic brain injury

“…These findings are consistent to the previous study of ours and the others in adult rats (Huang et al, 2013;Yang et al, 2015). Among a collection of therapeutic strategies against neurological diseases (Dock et al, 2015;Li et al, 2015;Lioutas et al, 2015;Merali et al, 2015;Ploughman et al, 2015;Qi et al, 2015;Reuter et al, 2015;Schlunk et al, 2015;Soliman et al, 2015;Zhu et al, 2015), medical gas regimens have been extensively explored with the advantage of administration feasibility (Harch, 2015;Herrera et al, 2015;Hu et al, 2015;Ichihara et al, 2015;Langston and Toombs, 2015;Miller et al, 2015;Parra et al, 2015;Stoller, 2015;Weaver and Liu, 2015;Yan et al, 2015). Emerging evidence has shown HBO induces neuroprotection against a variety of neurological disorders including severe TBI (Huang and Obenaus, 2011).…”

Molecular hydrogen: a therapeutic antioxidant and beyond

“…Since this landmark publication in Nature Medicine, research on the molecular hydrogen medicine has blossomed worldwide. Emerging evidence has demonstrated the pleiotropic therapeutic effects of molecular hydrogen in a variety of animal disease models and some human patients (Huang et al, 2010;Ohta, 2011;Dixon et al, 2013;Ishibashi et al, 2015;Kurokawa et al, 2015), which are comparable to what have been found with other traditional therapeutic gases regimens including hyperbaric/normobaric oxygen (Harch, 2015;Hu et al, 2015;Parra et al, 2015;Stoller, 2015;Weaver and Liu, 2015;Yan et al, 2015) and hyrogen sulfide (H 2 S) (Herrera et al, 2015;Langston and Toombs, 2015). H 2 is now considered as a signaling gaseous molecule with physiological functions similar to that of nitric oxide (NO), carbon monoxide (CO), and H 2 S (Kajimura et al, 2012).…”

For the pursuit of oxygen and carbon dioxide channels in mitochondria

“…The classical concept of the plasma membranes is extremely permeable to gases, which has been extended to the solubility-diffusion mechanism for the gas transport across plasma membrane, including O 2 and CO 2 (Finkelstein, 1976;Harch, 2015;Katz et al, 2015;Langston and Toombs, 2015;Parra et al, 2015;Stoller, 2015). It is generally believed that both O 2 and CO 2 molecules are transport across the plasma membrane through diffusion.…”